Skip to main content
. Author manuscript; available in PMC: 2018 Mar 29.
Published in final edited form as: Med Care. 2014 Sep;52(9):e58–e64. doi: 10.1097/MLR.0b013e318277eba5

TABLE 2.

Reliability and Sensitivity of Medicare Claims With Medical Record Abstraction for Prostate Cancer Surgery, Radiation Therapy, Hormonal Therapy, NPCR POCBP Study

Treatment* Claims Records Concordant Cases Claims (y)
Records (n)
Claims (n)
Records (y)
Sensitivity κ*
Surgery(n = 2700) 635 595 576 59 19 96.8 0.92
 Prostatectomy (radical, subtotal, segmental, simple) 487 490 477 10 13 97.3 0.97
 Cryotherapy 98 91 87 11 4 95.6 0.92
 Hyper/laser§ 28 12 7 21 5 58.3 0.35
Radiation therapy|| (n = 2696) 1382 1380 1327 55 53 96.2 0.92
 External beam 1103 825 786 317 39 95.3 0.72
 Brachytherapy 643 301 286 357 15 95.0 0.54
 Combination of external beam and brachytherapy 371 242 227 144 15 93.8 0.71
Hormonal therapy (LHRH agonists) (n = 2690) 1247 959 912 335 47 95.3 0.71
*

Unknown treatment excluded from analyses; TURP not considered surgery.

POCBP medical records used as gold standard.

Includes with or without RT or LHRH agonists

§

Includes laser ablation, hyperthermia, radiofrequency, or microwave treatments.

||

Includes with or without surgery or LHRH agonists.